111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
152.55%
Revenue growth exceeding 1.5x CX's 13.06%. David Dodd would verify if faster growth reflects superior business model.
No Data
No Data available this quarter, please select a different quarter.
152.55%
Gross profit growth exceeding 1.5x CX's 23.58%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-253.31%
EBITDA decline while CX shows 75.20% growth. Joel Greenblatt would examine position.
-160.70%
EBITDA margin decline while CX shows 54.97% growth. Joel Greenblatt would examine position.
-253.31%
Operating income decline while CX shows 70.77% growth. Joel Greenblatt would examine position.
-160.70%
Operating margin decline while CX shows 51.04% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-91.58%
Tax expense reduction while CX shows 95.05% growth. Joel Greenblatt would examine advantage.
91.58%
Net income growth while CX declines. John Neff would investigate advantages.
-24.14%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-100.00%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-100.00%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-100.00%
Share count reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.
-100.00%
Diluted share reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.